Suzanne A W Fuqua

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Tyrosine Kinase

Endoplasmic Reticulum

Top Venues

British journal of cancer

Molecular cancer therapeutics

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Anran Chen, Beom-Jun Kim, Aparna Mitra, Craig T Vollert, Jonathan T Lei, Diana Fandino, Meenakshi Anurag, Matthew V Holt, Xuxu Gou, Jacob B Pilcher, Matthew P Goetz, Donald W Northfelt, Susan G Hilsenbeck, C Gary Marshall, Marc L Hyer, Robert Papp, Shou-Yun Yin, Carmine De Angelis, Rachel Schiff, Suzanne A W Fuqua, Cynthia X Ma, Charles E Foulds, Matthew J Ellis
PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer. Molecular cancer therapeutics (2024)
Anran Chen, Beom-Jun Kim, Aparna Mitra, Craig T Vollert, Jonathan T Lei, Diana Fandino, Meenakshi Anurag, Matthew V Holt, Xuxu Gou, Jacob B Pilcher, Matthew P Goetz, Donald W Northfelt, Susan G Hilsenbeck, C Gary Marshall, Marc L Hyer, Robert Papp, Shou-Yun Yin, Carmine De Angelis, Rachel Schiff, Suzanne A W Fuqua, Cynthia X Ma, Charles E Foulds, Matthew J Ellis
PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer. Molecular cancer therapeutics (2024)
Songyeon Ahn, Jun Hyoung Park, Sandra L Grimm, Danthasinghe Waduge Badrajee Piyarathna, Tagari Samanta, Vasanta Putluri, Dereck Mezquita, Suzanne A W Fuqua, Nagireddy Putluri, Cristian Coarfa, Benny Abraham Kaipparettu
Metabolomic rewiring promotes endocrine therapy resistance in breast cancer. Cancer research (2023)
Suzanne A W Fuqua
Metastasis: complexity thwarts precision targeting. British journal of cancer 125 (8) (2021)
Sarah K Herzog, Suzanne A W Fuqua
ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges. British journal of cancer (2021)
Guowei Gu, Lin Tian, Sarah K Herzog, Yassine Rechoum, Luca Gelsomino, Meng Gao, Lili Du, Jin-Ah Kim, Derek Dustin, Hin Ching Lo, Amanda R Beyer, David G Edwards, Thomas Gonzalez, Anna Tsimelzon, Helen J Huang, Natalie M Fernandez, Sandra L Grimm, Susan G Hilsenbeck, Dan Liu, Jun Xu, Alyssa Alaniz, Shunqiang Li, Gordon B Mills, Filip Janku, Ralf Kittler, Xiang H F Zhang, Cristian Coarfa, Charles E Foulds, William Fraser Symmans, Sebastiano Andò, Suzanne A W Fuqua
Correction to: Hormonal modulation of ESR1 mutant metastasis. Oncogene (2021)
Derek Dustin, Guowei Gu, Amanda R Beyer, Sarah K Herzog, David G Edwards, Hangqing Lin, Thomas L Gonzalez, Sandra L Grimm, Cristian Coarfa, Doug W Chan, Beom-Jun Kim, Jean-Paul De La O, Matthew J Ellis, Dan Liu, Shunqiang Li, Alana L Welm, Suzanne A W Fuqua
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. British journal of cancer 124 (1) (2020)
Guowei Gu, Lin Tian, Sarah K Herzog, Yassine Rechoum, Luca Gelsomino, Meng Gao, Lili Du, Jin-Ah Kim, Derek Dustin, Hin Ching Lo, Amanda R Beyer, David G Edwards, Thomas Gonzalez, Anna Tsimelzon, Helen J Huang, Natalie M Fernandez, Sandra L Grimm, Susan G Hilsenbeck, Dan Liu, Jun Xu, Alyssa Alaniz, Shunqiang Li, Gordon B Mills, Filip Janku, Ralf Kittler, Xiang H F Zhang, Cristian Coarfa, Charles E Foulds, William Fraser Symmans, Sebastiano Andò, Suzanne A W Fuqua
Hormonal modulation of ESR1 mutant metastasis. Oncogene 40 (5) (2020)
Sasha M Pejerrey, Derek Dustin, Jin-Ah Kim, Guowei Gu, Yassine Rechoum, Suzanne A W Fuqua
The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer. Hormones & cancer 9 (4) (2018)